Statine based tripeptides as potent inhibitors of HIV-1 replication
- 30 October 1992
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 188 (2) , 873-878
- https://doi.org/10.1016/0006-291x(92)91137-f
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Productive infection of CD4+ cells by selected hiv strains is not inhibited by Anti-CD4 monoclonal antibodiesVirology, 1991
- Benzocycloalkyl amines as novel C-termini for HIV protease inhibitorsJournal of Medicinal Chemistry, 1991
- A Synthetic HIV-1 Protease Inhibitor with Antiviral Activity Arrests HIV-Like Particle MaturationScience, 1990
- High-level expression of self-processed HIV-1 protease in Escherichia coli using a synthetic geneBiochemical and Biophysical Research Communications, 1989
- Peptide substrates and inhibitors of the HIV-1 proteaseBiochemical and Biophysical Research Communications, 1989
- Detection and titration of neutralizing antibodies to HIV using an inhibition of the cytopathic effect of the virus on MT4 cellsJournal of Virological Methods, 1987
- Stereospecific synthesis of N-protected statine and its analogues via chiral tetramic acidJournal of the Chemical Society, Perkin Transactions 1, 1987
- Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque AssayScience, 1985
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983